Đăng xuất
Pregnancy: There is no or limited amount of data on the use of intranasal mometasone furoate in pregnant women. Studies in animals have shown reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions). As with other nasal corticosteroid preparations, BRUSONEX Nasal Spray should not be used in pregnancy unless the potential benefit to the mother justifies any potential risk to the mother, foetus or infant. Infants born of mothers who received corticosteroids during pregnancy should be observed carefully for hypoadrenalism.
Lactation: It is not known whether mometasone is excreted into breast milk. As with other nasal corticosteroid preparations, a decision must be made whether to discontinue breast-feeding or to discontinue/abstain from BRUSONEX Nasal Spray therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Fertility: There are no data on the effect of mometasone on human fertility. Fertility was unaffected following mometasone treatment in animal studies (see Pharmacology: Toxicology: Preclinical safety data under Actions).
